Reactive oxygen species‐responsive dual‐targeted nanosystem promoted immunogenic cell death against breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reactive oxygen species‐responsive dual‐targeted nanosystem promoted immunogenic cell death against breast cancer

Published:2022-08-03 Issue: Volume: Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioengineering & Transla Med

Author:

Banstola Asmita¹²^ORCID,Pandit Mahesh³,Duwa Ramesh¹,Chang Jae‐Hoon³,Jeong Jee‐Heon⁴^ORCID,Yook Simmyung¹

Affiliation:

1. College of Pharmacy Keimyung University Daegu South Korea

2. Department of Dermatology, Harvard Medical School Wellman Center for Photomedicine, Massachusetts General Hospital Boston Massachusetts USA

3. College of Pharmacy Yeungnam University Gyeongsan Gyeongbuk South Korea

4. Department of Precision Medicine, School of Medicine Sungkyunkwan University Suwon South Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10379

Reference46 articles.

1. PD‐L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade;Peng Q;Nat Commun,2020

2. Immunoadjuvants for cancer immunotherapy: A review of recent developments

3. Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants

4. Immunogenic cell death in cancer therapy: Present and emerging inducers

5. Induction of immunogenic cell death in cancer cells by a photoactivated platinum(iv) prodrug

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Intratumoral Drug Delivery Based Strategies for Antitumor Therapy;Drug Design, Development and Therapy;2024-06

2. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

3. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy;Frontiers in Immunology;2024-04-29

4. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy;Journal of Controlled Release;2024-01

5. Advanced technologies for biomedical applications by emerging researchers in Asia‐Pacific;Bioengineering & Translational Medicine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3